New Bill Would Reshape Drug Patent Cases In Uncertain Ways
A new bill in Congress aimed at making it easier to invalidate drug patents has left attorneys with many questions, with both supporters and critics of the proposal saying it's unclear...To view the full article, register now.
Already a subscriber? Click here to view full article